Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors

Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern pose a challenge to the effectiveness of current vaccines. A vaccine that could prevent infection caused by known and future variants of concern as well as infection with pre-emergent sarbecoviruses (i.e., thos...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chee-Wah, Chia, Wan-Ni, Young, Barnaby E., Zhu, Feng, Lim, Beng-Lee, Sia, Wan-Rong, Thein, Tun-Linn, Chen, Mark I.-C., Leo, Yee-Sin, Lye, David C., Wang, Lin-Fa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422514/
https://www.ncbi.nlm.nih.gov/pubmed/34407341
http://dx.doi.org/10.1056/NEJMoa2108453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422514/
https://www.ncbi.nlm.nih.gov/pubmed/34407341
http://dx.doi.org/10.1056/NEJMoa2108453

Ejemplares similares